CMPS Live signals | Maximize Profits with Getagraph.com

BUY 102488 min ago

@ $10.36

Issued: 14 Feb 2024 @ 15:35

Return: -24.13%

Previous signal: Feb 14 - 13:08

Previous signal: Sell

Return: -3.09 %

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Stats
Today's Volume	1.49M
Average Volume	702 469
Market Cap	486.88M
EPS	$0 ( 2024-02-29 )
Next earnings date	( $-0.330 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.39
ATR14	$0.0130 (0.17%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-16	Goldsmith George Jay	Sell	23 881	Ordinary Shares
2024-04-16	Goldsmith George Jay	Sell	23 880	Ordinary Shares
2024-04-17	Goldsmith George Jay	Sell	10 850	Ordinary Shares
2024-04-17	Goldsmith George Jay	Sell	10 850	Ordinary Shares
2024-04-16	Malievskaia Ekaterina	Sell	23 881	Ordinary Shares

INSIDER POWER
-21.91
Last 98 transactions
Buy: 820 261 \| Sell: 1 253 383

Volume Correlation

Long: -0.12 (neutral)

Short: -0.08 (neutral)

Signal:(77.707) Neutral

COMPASS Pathways Plc - Correlation

10 Most Positive Correlations
RMRM	0.901
GAINL	0.848
ONCS	0.826
AFIN	0.82
OPOF	0.817

10 Most Negative Correlations
ZD	-0.84
RTH	-0.807

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

COMPASS Pathways Plc - Correlation - Currency/Commodity

0.69
( moderate )

-0.40
( neutral )

0.00
( neutral )

0.62
( weak )

-0.13
( neutral )

-0.48
( neutral )

COMPASS Pathways Plc - Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-242 938 (0.00 %)
EPS:	$-2.33

Q4	2023
Revenue:	$3.68M
Gross Profit:	$1.84M (50.00 %)
EPS:	$-0.530

Q3	2023
Revenue:	$0
Gross Profit:	$-658 158 (0.00 %)
EPS:	$-0.670

Q2	2023
Revenue:	$0
Gross Profit:	$-590 893 (0.00 %)
EPS:	$-0.620

Financial Reports:

No articles found.

COMPASS Pathways Plc -

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.